FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899740919> ?p ?o ?g. }

• W2899740919 abstract "Background: There is a great unmet medical need for new anticancer small molecule therapeutics. Exhaustive literature review suggests that benzothiazole derivatives have good potential to exhibit anticancer activity. Compounds that inhibit the kinase activity of EGFR are of potential interest as new antitumor agent. Objective: To design, synthesize and carry out in silico along with biological evaluation of 2- substituted benzothiazole compounds with EGFR inhibitory activity. Methods: Benzothiazole derivatives designed from molecular docking method for potential EGFR tyrosine kinase inhibition have been synthesized based on the docking results and characterized. Insilico studies were carried out to understand the mode of EGFR enzyme inhibition by our molecules. As a preliminary study, these compounds were first screened for antioxidant activity and then for anticancer activity against MCF-7 cell lines and A549 cell line. Results: Compound B5 showed potent anticancer activity on MCF-7 cell line with IC50 value of 9.7µM and compound B8 showed significant anticancer activity on A549 cell line with IC50 value of 49.7μM in comparison with the standard drug Doxorubicin (IC50 = 1.4µM on MCF-7 and 1.0µM on A549 cell lines). In EGFR inhibitory activity B8 showed maximum activity on A549 cell line by inactivating 69.10% of EGFR phosphorylation and B7 showed maximum activity on MCF-7 cell line by inactivating 41.90% of EGFR phosphorylation in comparison with the reference drug Gefitinib. Molecular dynamics simulation studies suggest that benzothiazole derivative could also bind to allosteric site and inhibit the EGFR enzyme activity. Conclusion: Reported compounds have shown potent anticancer activity through EGFR inhibition by possibly binding at allosteric site." @default.
• W2899740919 created "2018-11-16" @default.
• W2899740919 creator A5028542106 @default.
• W2899740919 creator A5033425665 @default.
• W2899740919 creator A5034125014 @default.
• W2899740919 creator A5054933168 @default.
• W2899740919 date "2019-08-08" @default.
• W2899740919 modified "2023-09-27" @default.
• W2899740919 title "Design, Synthesis, Biological Evaluation and In Silico Studies of Few Novel 2-Substituted Benzothiazole Derivatives as Potential EGFR Inhibitors" @default.
• W2899740919 cites W1965935095 @default.
• W2899740919 cites W1978477308 @default.
• W2899740919 cites W1983189292 @default.
• W2899740919 cites W1992772000 @default.
• W2899740919 cites W2004870897 @default.
• W2899740919 cites W2005704211 @default.
• W2899740919 cites W2014514137 @default.
• W2899740919 cites W2018153260 @default.
• W2899740919 cites W2042270035 @default.
• W2899740919 cites W2046514328 @default.
• W2899740919 cites W2062419532 @default.
• W2899740919 cites W2075209098 @default.
• W2899740919 cites W2079555477 @default.
• W2899740919 cites W2083583820 @default.
• W2899740919 cites W2095381863 @default.
• W2899740919 cites W2106830844 @default.
• W2899740919 cites W2110500210 @default.
• W2899740919 cites W2132908735 @default.
• W2899740919 cites W2134530125 @default.
• W2899740919 cites W2169988894 @default.
• W2899740919 cites W2617658365 @default.
• W2899740919 cites W2951785431 @default.
• W2899740919 doi "https://doi.org/10.2174/1570180816666181108112228" @default.
• W2899740919 hasPublicationYear "2019" @default.
• W2899740919 type Work @default.
• W2899740919 sameAs 2899740919 @default.
• W2899740919 citedByCount "1" @default.
• W2899740919 countsByYear W28997409192020 @default.
• W2899740919 crossrefType "journal-article" @default.
• W2899740919 hasAuthorship W2899740919A5028542106 @default.
• W2899740919 hasAuthorship W2899740919A5033425665 @default.
• W2899740919 hasAuthorship W2899740919A5034125014 @default.
• W2899740919 hasAuthorship W2899740919A5054933168 @default.
• W2899740919 hasConcept C104317684 @default.
• W2899740919 hasConcept C159110408 @default.
• W2899740919 hasConcept C170493617 @default.
• W2899740919 hasConcept C185592680 @default.
• W2899740919 hasConcept C202751555 @default.
• W2899740919 hasConcept C2775905019 @default.
• W2899740919 hasConcept C2777456753 @default.
• W2899740919 hasConcept C2777506169 @default.
• W2899740919 hasConcept C2777752497 @default.
• W2899740919 hasConcept C2779438470 @default.
• W2899740919 hasConcept C2780580887 @default.
• W2899740919 hasConcept C41685203 @default.
• W2899740919 hasConcept C54355233 @default.
• W2899740919 hasConcept C55493867 @default.
• W2899740919 hasConcept C71924100 @default.
• W2899740919 hasConcept C81729549 @default.
• W2899740919 hasConcept C81885089 @default.
• W2899740919 hasConcept C86803240 @default.
• W2899740919 hasConcept C98274493 @default.
• W2899740919 hasConceptScore W2899740919C104317684 @default.
• W2899740919 hasConceptScore W2899740919C159110408 @default.
• W2899740919 hasConceptScore W2899740919C170493617 @default.
• W2899740919 hasConceptScore W2899740919C185592680 @default.
• W2899740919 hasConceptScore W2899740919C202751555 @default.
• W2899740919 hasConceptScore W2899740919C2775905019 @default.
• W2899740919 hasConceptScore W2899740919C2777456753 @default.
• W2899740919 hasConceptScore W2899740919C2777506169 @default.
• W2899740919 hasConceptScore W2899740919C2777752497 @default.
• W2899740919 hasConceptScore W2899740919C2779438470 @default.
• W2899740919 hasConceptScore W2899740919C2780580887 @default.
• W2899740919 hasConceptScore W2899740919C41685203 @default.
• W2899740919 hasConceptScore W2899740919C54355233 @default.
• W2899740919 hasConceptScore W2899740919C55493867 @default.
• W2899740919 hasConceptScore W2899740919C71924100 @default.
• W2899740919 hasConceptScore W2899740919C81729549 @default.
• W2899740919 hasConceptScore W2899740919C81885089 @default.
• W2899740919 hasConceptScore W2899740919C86803240 @default.
• W2899740919 hasConceptScore W2899740919C98274493 @default.
• W2899740919 hasLocation W28997409191 @default.
• W2899740919 hasOpenAccess W2899740919 @default.
• W2899740919 hasPrimaryLocation W28997409191 @default.
• W2899740919 hasRelatedWork W1185762171 @default.
• W2899740919 hasRelatedWork W2069341703 @default.
• W2899740919 hasRelatedWork W2069625758 @default.
• W2899740919 hasRelatedWork W2104005953 @default.
• W2899740919 hasRelatedWork W2134530125 @default.
• W2899740919 hasRelatedWork W2136704710 @default.
• W2899740919 hasRelatedWork W2213661638 @default.
• W2899740919 hasRelatedWork W2283431786 @default.
• W2899740919 hasRelatedWork W2326403221 @default.
• W2899740919 hasRelatedWork W2337170247 @default.
• W2899740919 hasRelatedWork W2554557808 @default.
• W2899740919 hasRelatedWork W2765903344 @default.
• W2899740919 hasRelatedWork W2766252010 @default.
• W2899740919 hasRelatedWork W2766276262 @default.
• W2899740919 hasRelatedWork W2903433160 @default.
• W2899740919 hasRelatedWork W2952691035 @default.
• W2899740919 hasRelatedWork W2952910425 @default.

• next